Cyclobenzaprine or oxycodone show no benefit to naproxen treatment of acute low back pain .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain: A Randomized Clinical Trial
JAMA. 2015 Oct 20;314(15):1572-80.323 patients with acute low back pain were randomized to receive naproxen with 1 of 3 concurrent medications: cyclobenzaprine, oxycodone/acetaminophen, or a placebo. The purpose of the study was to compare the efficacy of these treatments and determine if the addition of these skeletal muscle relaxants and opioids to naproxen treatment provided further benefits to the patient. Improvement to RMDQ disability score was similar between all 3 groups up to 3 months after the start of treatment, but the risk of adverse events was higher in patients receiving cyclobenzaprine or oxycodone/acetaminophen compared to those receiving placebo. No other differences were observed between treatment groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
